Right heart failure future or investigational therapies: Difference between revisions
New page: {{Right heart failure}} {{CMG}} ==References== {{Reflist|2}} Category:Cardiology Category:Pulmonology Category:Emergency medicine Category:Mature chapter |
No edit summary |
||
Line 1: | Line 1: | ||
{{Right heart failure}} | {{Right heart failure}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
A [[right ventricular assist device]] ([[RVAD]]) can be a temporary therapy for patients with an acute exacerbation of right heart failure. | |||
==References== | ==References== |
Revision as of 19:34, 3 September 2011
Right heart failure Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Right heart failure future or investigational therapies On the Web |
American Roentgen Ray Society Images of Right heart failure future or investigational therapies |
FDA on Right heart failure future or investigational therapies |
CDC on Right heart failure future or investigational therapies |
Right heart failure future or investigational therapies in the news |
Blogs on Right heart failure future or investigational therapies |
Risk calculators and risk factors for Right heart failure future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
A right ventricular assist device (RVAD) can be a temporary therapy for patients with an acute exacerbation of right heart failure.